Adicet Bio Revenue

Revenue (ttm)

n/a

Revenue Growth

n/a

P/S Ratio

n/a

Revenue / Employee

n/a

Employees

102

Market Cap

91.69M

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	-	-	-
Dec 31, 2024	-	-	-
Dec 31, 2023	-	-	-
Dec 31, 2022	24.99M	15.26M	156.83%
Dec 31, 2021	9.73M	-8.17M	-45.65%
Dec 31, 2020	Upgrade Pro	Upgrade Pro	Upgrade Pro
Dec 31, 2019	Upgrade Pro	Upgrade Pro	Upgrade Pro
Dec 31, 2018	Upgrade Pro	Upgrade Pro	Upgrade Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Pelthos Therapeutics	16.80M
Coya Therapeutics	7.95M
Rani Therapeutics Holdings	1.63M
NRx Pharmaceuticals	1.23M
Inovio Pharmaceuticals	65.34K
eXoZymes	-700.00

Revenue Rankings

ACET News

7 weeks ago - Adicet Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Highlights Recent Company Progress - Business Wire
3 months ago - Adicet Bio to Present at the Guggenheim Emerging Outlook: Biotech Summit 2026 - Business Wire
4 months ago - Adicet Bio Provides Corporate Update and Highlights Expected 2026 Milestones - Business Wire
4 months ago - Adicet Bio Announces Reverse Stock Split - Business Wire
5 months ago - Adicet Bio Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4) - Business Wire
6 months ago - Adicet Bio Transcript: Guggenheim Securities 2nd Annual Healthcare Innovation Conference - Transcripts
6 months ago - Adicet Bio Reports Third Quarter 2025 Financial Results and Provides Business Updates - Business Wire
6 months ago - Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - Business Wire

More News